New program will increase access to affordable genetic testing while also helping to identify and elevate high-risk patient careSALT LAKE...
FLORHAM PARK, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a...
Modular panel design sets foundation for continued expansion of applications on the PhenoCycler®-Fusion systemFirst protein panel commercially available at AACR...
UTRECHT, The Netherlands, April 12, 2023 (GLOBE NEWSWIRE) -- ViCentra B.V., the company behind Kaleido, one of the world’s smallest,...
LONDON, April 12, 2023 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that its Chief Executive Officer Michael Parini...
BOSTON, April 12, 2023 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of...
WALTHAM, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing...
WALTHAM, Mass. and BOULDER, Colo., April 12, 2023 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...
Pharmaceutical Veteran to Help Propel Manufacturing Scale-Up as Clinical-Stage Biotech Prepares to Enter Phase 2 Clinical TrialsNEW HAVEN, Conn., April...
FLORHAM PARK, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing...
Enable Cloud Platform trained on high plex spatial imaging datasets across 20,000 samples run on the PhenoCycler® SystemCommercial launch at...
Preliminary revenue to be within the range of $7.3 - $7.8 million and expected to be the strongest first-quarter results...
LAFAYETTE, La., April 11, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national...
Virtual event on Wednesday, May 3rd at 1:00 PM ET will feature key opinion leader Hendrik Scholl, M.D. from the...
Turnover at €2 billion 749 million, with growth of 13.6% over 2021The European market remains at the center, with significant...
ARLINGTON, Va., April 11, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to...
“The Invisible Machine” reveals the startling truth about trauma and the scientific breakthrough that could transform millions of lives The...
Leading Diagnostic Healthcare Company Begins Manufacturing of Ocular Immunoglobulin (IgE), Lactoferrin Tests to Fulfill Orders From Commercialization Partner SAN DIEGO,...
Sabizabulin inhibited the cell release and cell-to-cell spread of poxvirus in a preclinical study Veru further expands study of sabizabulin...
Dr. Redkar to discuss importance of HGF/cMET pathway, which can play critical role in origin of several cancersFOSTER CITY, Calif.,...